[Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].

Abstract

Substance use disorder is the most common psychiatric comorbidity in patients with schizophrenia, revealing prevalence rates of up to 65%. Recommendations of antipsychotic pharmacotherapy in schizophrenia are based on studies excluding patients with this double diagnosis. In this systematic review the available pharmacological studies in this subgroup of… (More)

Topics

  • Presentations referencing similar topics